Figure 5
Figure 5. Principle and kinetics of the serum TXB2 ex vivo assay. (A) The chain of enzymatic reactions triggered by whole blood clotting in vitro at 37°C. Thrombin generated during blood clotting activates platelet phospholipases A2 (PLA2), which releases AA from membrane phospholipids. AA is the substrate of the sequential action of COX-1 and TX synthase, resulting in TXA2 generation. Because of chemical instability of its oxane ring, TXA2 is rapidly hydrolyzed to the chemically stable, biologically inactive hydration product, TXB2, which can be measured in serum with high sensitivity and specificity. (B) The kinetics of TXB2 production during whole blood clotting at 37°C and based on data from Patrono et al.61

Principle and kinetics of the serum TXB2 ex vivo assay. (A) The chain of enzymatic reactions triggered by whole blood clotting in vitro at 37°C. Thrombin generated during blood clotting activates platelet phospholipases A2 (PLA2), which releases AA from membrane phospholipids. AA is the substrate of the sequential action of COX-1 and TX synthase, resulting in TXA2 generation. Because of chemical instability of its oxane ring, TXA2 is rapidly hydrolyzed to the chemically stable, biologically inactive hydration product, TXB2, which can be measured in serum with high sensitivity and specificity. (B) The kinetics of TXB2 production during whole blood clotting at 37°C and based on data from Patrono et al.61 

Close Modal

or Create an Account

Close Modal
Close Modal